John B. Buse, University of North Carolina Health Care (IMAGE)
Caption
“The results of this study will be helpful to both doctors and patients in shared decision-making about which of these two drugs is better suited for a particular patient,” said John B. Buse, M.D., Ph.D., first author of the study. Dr. Buse is division chief of endocrinology and metabolism in the University of North Carolina School of Medicine and director of the UNC Diabetes Care Center.
Credit
UNC Medical Center News Office
Usage Restrictions
None
License
Licensed content